Enric Monreal
Overview
Explore the profile of Enric Monreal including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
43
Citations
207
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Garcia-Dominguez J, Maurino J, Meca-Lallana J, Landete L, Meca-Lallana V, Garcia-Arcelay E, et al.
J Pers Med
. 2025 Feb;
15(2).
PMID: 39997346
Cognitive impairment has an impact upon the function and quality of life of patients with multiple sclerosis (MS). High-serum neurofilament light-chain (sNfL) levels predict disease progression and are also associated...
2.
Comabella M, Pappolla A, Monreal E, Fissolo N, Sao-Aviles A, Arrambide G, et al.
Neurol Neuroimmunol Neuroinflamm
. 2025 Jan;
12(2):e200370.
PMID: 39879564
Background And Objectives: Invasive procedures may delay the diagnostic process in multiple sclerosis (MS). We investigated the added value of serum neurofilament light chain (sNfL), glial fibrillary acidic protein (sGFAP),...
3.
Rodriguez-Jorge F, Fernandez-Velasco J, Villarrubia N, Gracia-Gil J, Fernandez E, Meca-Lallana V, et al.
Front Immunol
. 2025 Jan;
15:1535051.
PMID: 39749346
[This corrects the article DOI: 10.3389/fimmu.2024.1480676.].
4.
Sainz-Amo R, Rodero-Romero A, Monreal E, Chico-Garcia J, Rodriguez-Jorge F, Fernandez-Velasco J, et al.
Int J Mol Sci
. 2024 Dec;
25(23).
PMID: 39684862
Natalizumab is a highly effective therapy for multiple sclerosis (MS). The aim of this study was to evaluate serum neurofilament light chain (sNfL) and serum glial fibrillary acidic protein (sGFAP)...
5.
Comabella M, Hegen H, Villar L, Rejdak K, Sao-Aviles A, Behrens M, et al.
J Neurol
. 2024 Dec;
272(1):26.
PMID: 39666032
Background And Objectives: The impact of viral infections on disease susceptibility and progression has predominantly been studied in patients with relapse-onset MS (RMS). Here, we determined immune responses to ubiquitous...
6.
Rodriguez-Jorge F, Fernandez-Velasco J, Villarrubia N, Gracia-Gil J, Fernandez E, Meca-Lallana V, et al.
Front Immunol
. 2024 Nov;
15:1480676.
PMID: 39606235
Objective: To ascertain the changes of serum neurofilament light chain (sNfL) and glial fibrillary acidic protein (sGFAP) values in relapsing-remitting multiple sclerosis (RRMS) patients treated with ocrelizumab and their association...
7.
Dominguez-Mozo M, Casanova I, Monreal E, Costa-Frossard L, Sainz-de-la-Maza S, Sainz-Amo R, et al.
Int J Mol Sci
. 2024 Sep;
25(18).
PMID: 39337499
microRNAs (miRNAs) are promising biomarkers for many diseases, including multiple sclerosis (MS). The neurofilament light chain (NfL) is a biomarker that can detect axonal damage in different neurological diseases. The...
8.
Chico-Garcia J, Sainz Amo R, Monreal E, Sainz De La Maza S, Rodriguez Jorge F, Masjuan J, et al.
Mult Scler
. 2024 Sep;
30(10):1341-1349.
PMID: 39246042
Background: Tapping speed (TS) correlates with baseline disability scales in people with multiple sclerosis (pwMS). Objective: The study aimed to address if progression independent of relapse activity (PIRA) could be...
9.
Sainz De La Maza S, Rodero-Romero A, Monreal E, Chico-Garcia J, Villarrubia N, Rodriguez-Jorge F, et al.
Front Immunol
. 2024 Sep;
15:1439393.
PMID: 39238642
Objective: To evaluate the safety of COVID-19 vaccines in patients with multiple sclerosis (MS) by assessing their impact on serum neurofilament light chain (sNfL) levels as a marker of neuroaxonal...
10.
Sainz-Amo R, Rodero Romero A, Monreal E, Chico Garcia J, Fernandez Velasco J, Villarrubia N, et al.
Front Immunol
. 2024 Sep;
15:1454474.
PMID: 39224593
Introduction: Alemtuzumab is a highly effective pulsed immune reconstitution therapy for multiple sclerosis (MS). Aim: To evaluate serum neurofilament light chain (sNfL) and serum glial fibrillary acidic protein (sGFAP) in...